SCIMITAR EQUITY
About Us Equity Research Disclosure Contact







New Optimizing Investor Attraction
06.16.08 VioQuest Pharmaceuticals, Inc.
(VOQP.OB; NASDAQ)
Robust Pipeline of Niche’ Cancer Therapies with Billion Dollar Upside.
05.20.08 ART Advanced Research Technologies, Inc.
(ARA.TO, TSX)
Getting Past a Year of Transformation.
  More...

Scimitar Equity is an independent equity research firm focused on emerging healthcare companies. We employ quantitative analytics and qualitative detail to provide investors a balanced and objective perspective. Our timely, comprehensive research and insightful analysis help define the short, near and long term potential useful in making investment decisions.

Investors and shareholders need independent verification that companies are meeting milestones and reaching established goals.

Through long-standing relationships with asset managers, hedge funds, private-equity firms and institutional investors, we have become a trusted source of intelligence on emerging healthcare companies for investment professionals.